Clinical trial
Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)
NCT05124483 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)
- Lead sponsor
- University Medical Center Groningen
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 21, 2022
- Completion date
- February 1, 2023
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.